Apellis Pharmaceuticals, Inc. (APLS)

20.07 -0.08 (-0.40%) USD  |  NASDAQ  |  Mar 06, 16:00
20.08 +0.01 (+0.05%) After-Hours: 20:00
More

Apellis Pharmaceuticals Price to Book Value (3y Mean)

Price to Book Value (3y Mean) Chart

View Price to Book Value (3y Mean) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value (3y Mean) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Value (3y Mean) Range, Past 5 Years

View Price to Book Value (3y Mean) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value (3y Mean) Benchmarks

View Price to Book Value (3y Mean) Benchmarks
Start Trial
Amneal Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. --
BioMarin Pharmaceutical, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade